Credit Suisse Ag Oramed Pharmaceuticals Inc. Transaction History

Credit Suisse Ag

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$3.72 - $9.0 $77,335 - $187,101	-20,789 Reduced 99.9%	20 $0
Q1 2022 May 16, 2022	BUY	$8.19 - $13.89 $21,998 - $37,308	2,686 Added 14.82%	20,809 $180,000
Q4 2021 Feb 14, 2022	BUY	$12.98 - $29.75 $235,236 - $539,159	18,123 New	18,123 $259,000

7.4M

2.1K

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $92M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.